The anti-infective effect of β-glucans in children
Wzorek-Łyczko K, Woźniak W, Piwowarczyk A, Kuchar E
Published in Int J Vitam Nutr Res, Vol. 94 (3-4), pp. 296-307
Methodology
PRISMA scoping review of 12 studies of beta-glucans in children (8 randomised placebo-controlled), searched to May 2021. Five used pleuran at 10 mg per 5 kg of body weight a day.
Key Findings
Ten of 12 studies found fewer respiratory infections or milder upper respiratory symptoms, and 10 reported good tolerance and safety.
Conclusions
The authors judged the benefit-risk balance favourable but called for higher-quality trials.
Limitations
Scoping review without pooled effect sizes; mixed products and designs.
Supplements Studied
Ten out of twelve trials demonstrated the effectiveness of β-glucans
Ten out of twelve trials demonstrated the effectiveness of β-glucans
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.